SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotransplant(BTRN)
BTRN 35.400.0%Nov 28 4:00 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Spekulatius who wrote (852)3/12/2001 11:50:37 PM
From: scaram(o)uche  Read Replies (1) of 1475
 
Described in the thread......... the last two offerings for BTRN were poorly timed. Shares were sold at a discount to market, and I was big-time ticked. Moreover, the investors bailed early and in the open market.

Soon after the last funding, we hit the sector rally. BTRN got a bit too fancy, and missed the window. They always seem to overestimate their capacity to generate investor interest and respect, and they've waited for a better share price to sell shares when the share price was pretty damn decent.

I guess that's one reason that I like them......... they consider their work to be of great value. So do I.

However, it's added up to one big, naive mess.

Bottom line....... there's more dilution coming than was necessary. Very frustrating...... I expected (1) MEDI to move faster, and (2) to therefore have "yes or no" data in hand by now for 507. Now we're caught trying to support a long-term program when the near-term promise is in the slow hands of Young et al.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News